Health Minister Carla Visotti has announced that vaccines from Argentine AstraZeneca and modern laboratories will be used as the second dose to complete the Kovid-19 immunization among Sputnik V recipients.

“The initial results of an interim analysis on security and resilience are satisfactory and encouraging,” the minister said.

Sputnik V was the first Kovid-19 vaccine to reach Argentina in December 2020. Eight months later, the second dose is low Delta variant, Very contagious.

Given the potential risk, the government has set a target of reaching at least 60% of the population over the age of 50 by the end of August with a complete vaccination schedule. To meet this, the minister said 2.3 million doses are needed.

As of this Wednesday, 25.5 million people (56.6% of the population) had received at least the first dose, of which 7.5 million (16.6%) were within the complete framework.

Richmond, a private laboratory in Argentina, has promised to deliver about 3 million doses of Sputnik V before the end of the month, after passing its first samples of quality control.

Argentina has recorded about five million infections and more than 106,700 deaths since the outbreak.